(Q51802017)
Statements
Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite (English)
Rena Nishizawa
Toshihiko Nishiyama
Katsuya Hisaichi
Naoki Matsunaga
Chiaki Minamoto
Hiromu Habashita
Yoshikazu Takaoka
Masaaki Toda
Shiro Shibayama
Hideaki Tada
Kenji Sagawa
Daikichi Fukushima
Hiroaki Mitsuya
1 November 2006